India-Argentina trade talks boost pharma access
Analysis based on 23 articles · First reported Aug 23, 2026 · Last updated Aug 31, 2026
The easing of pharmaceutical and agricultural market access is expected to boost Indian exports to Argentina, benefiting Indian pharma and agri companies. The broader trade diversification push in South America, including potential PTA expansions, could enhance bilateral trade flows and investment, particularly in lithium and other critical minerals.
India and Argentina held the fourth Joint Trade Committee (JTC) meeting in Buenos Aires on August 24, 2026, led by Commerce Secretary Rajesh Agrawal and Argentine Secretary Fernando Brun. Argentina committed to upgrading India from Annex II to Annex I under its pharmaceutical regulatory framework, easing entry for Indian medicines. Both sides agreed to improve market access for Indian agricultural products, with technical talks on SPS measures for onions, milk, grapes, potatoes, bananas, and pulses. Bilateral trade crossed $6.5 billion in 2025, growing over 17%, making India Argentina's fifth-largest trading partner. The JTC also reviewed investments in mining, energy, and infrastructure, including India — Khanij Bidesh India Limited's lithium project in Catamarca. Cooperation areas include aviation, space, telecom, and digital services. Progress was made on the India-Mercosur PTA expansion, including terms of reference and digital certificates of origin. A business forum on August 25 featured India's largest-ever business delegation to Argentina, with over 25 leaders from UPL Limited, Kirloskar, and Aditya Birla Group. The visit also covered trade talks with Brazil and Chile, including the proposed CEPA with Chile and the WTO sugar dispute with Brazil.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard